Health News

(Reuters Health) - High school students in the U.S. are a lot more sober than they used to be, a new study suggests. More
Bulgaria reported on Thursday another case of the highly contagious Peste des Petits Ruminants (PPR) close to the border with Turkey. More
Allergan Plc and Molecular Partners AG said on Thursday their treatment for neovascular age-related macular degeneration, a leading cause of vision loss among people over 65, met the main goal in two late-stage studies. More
Mersana Therapeutics said on Thursday an early stage trial testing its lead cancer drug has been put on partial hold by the U.S. Food and Drug Administration after a patient's death was possibly linked to the treatment. More
The Chinese bulk manufacturer of the common blood and heart drug valsartan said it was recalling the product from consumers in the United States and would halt supplies to the country, after an impurity linked to cancer had been detected. More
Roche's hopes of clinching more of the lung cancer treatment market with its Tecentriq immunotherapy had a major setback on Thursday, when a trial failed to deliver survival data the Swiss drugmaker needs to challenge rival Merck. More
U.S. President Donald Trump on Thursday thanked two major drug companies for not raising their prices and said his administration was working toward "substantially" cutting prescription-drug prices. More
Britain's Barclays on Thursday appointed Darren Campili as vice chairman of healthcare banking, effective from towards the end of the summer. More
Roche's Tecentric immunotherapy mixed with chemotherapy has not yet achieved a hoped-for overall survival target in first-line lung cancer treatment, the Swiss drugmaker said on Thursday. More
Novartis said on Thursday it will pay 95 million euros ($110.49 million) to Galapagos and MorphoSys to license a prospective medicine targeting the skin condition atopic dermatitis, as the Swiss drugmaker strengthens its foothold in immunology. More
Federal prosecutors on Wednesday charged a pharmacy technician who worked at a hospital with making false statements during an investigation related to a Massachusetts compounding pharmacy at the center of a deadly fungal meningitis outbreak in 2012. More
(Reuters Health) - Over nearly a decade, deaths from liver disease have been rising rapidly in the U.S., new data show. More
(Reuters Health) - Even when traffic fumes permeate the air, it's still better for your heart if you get outside and exercise than if you spend all day sitting inside, a recent study suggests. More
(Reuters Health) - Omega-3 fatty acids have long been touted as heart healthy, but taking them in supplement form does little to protect against heart disease, a large new analysis suggests. More
AngioDynamics Inc has agreed to pay the U.S. government $12.5 million to resolve allegations it caused healthcare providers to submit false claims to federal healthcare programs over the use of two medical devices, the Justice Department said on Wednesday. More